Literature DB >> 18940582

ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors?

Paolo Calabresi1, Massimiliano Di Filippo.   

Abstract

The midbrain dopaminergic system is a key element in the control of motor activity, cognition, and the motivational effects of drugs of abuse, including nicotine. In this issue of Neuron, Drenan et al. find that alpha6-containing nicotinic acetylcholine receptors might selectively activate mesolimbic and mesostriatal dopaminergic neurons, enhancing striatal dopamine release and its behavioral consequences.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18940582     DOI： 10.1016/j.neuron.2008.09.031

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


  10 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Targeting nicotinic receptors for Parkinson's disease therapy.

Authors:  Maryka Quik; Tanuja Bordia; Luping Huang; Xiomara Perez
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

Review 3.  Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.

Authors:  Maryka Quik; Xiomara A Perez; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

4.  Chronic diphenhydramine abuse and withdrawal: A diagnostic challenge.

Authors:  Jagroop S Saran; Richard L Barbano; Rachel Schult; Timothy J Wiegand; Olga Selioutski
Journal:  Neurol Clin Pract       Date:  2017-10

5.  Characterizing functional α6β2 nicotinic acetylcholine receptors in vitro: mutant β2 subunits improve membrane expression, and fluorescent proteins reveal responsive cells.

Authors:  Cheng Xiao; Rahul Srinivasan; Ryan M Drenan; Elisha D W Mackey; J Michael McIntosh; Henry A Lester
Journal:  Biochem Pharmacol       Date:  2011-05-17       Impact factor: 5.858

6.  Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.

Authors:  P Garção; E C Szabó; S Wopereis; A A Castro; Â R Tomé; R D Prediger; R A Cunha; P Agostinho; A Köfalvi
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.

Authors:  Yoko Hagino; Shinya Kasai; Masayo Fujita; Susumu Setogawa; Hiroshi Yamaura; Dai Yanagihara; Makoto Hashimoto; Kazuto Kobayashi; Herbert Y Meltzer; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

8.  Identification of transcriptome alterations in the prefrontal cortex, hippocampus, amygdala and hippocampus of suicide victims.

Authors:  Daniela Glavan; Victor Gheorman; Andrei Gresita; Dirk M Hermann; Ion Udristoiu; Aurel Popa-Wagner
Journal:  Sci Rep       Date:  2021-09-22       Impact factor: 4.379

9.  Regulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapses.

Authors:  Laurent Ladepeche; Luting Yang; Delphine Bouchet; Laurent Groc
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

10.  Central Thalamic Deep-Brain Stimulation Alters Striatal-Thalamic Connectivity in Cognitive Neural Behavior.

Authors:  Hui-Ching Lin; Han-Chi Pan; Sheng-Huang Lin; Yu-Chun Lo; Elise Ting-Hsin Shen; Lun-De Liao; Pei-Han Liao; Yi-Wei Chien; Kuei-Da Liao; Fu-Shan Jaw; Kai-Wen Chu; Hsin-Yi Lai; You-Yin Chen
Journal:  Front Neural Circuits       Date:  2016-01-13       Impact factor: 3.492
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.